Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCode ▲DrugDate fromSubject
 4.1.2023Viatris Limited (VIM)9997COgivri 150 mg prášok na infúzny koncentrát (plc ifc 1x150 mg (liek.inj.skl.))5.1.2023R
 10.3.2023Viatris Limited (VIM)9997COgivri 150 mg prášok na infúzny koncentrát (plc ifc 1x150 mg (liek.inj.skl.))10.3.2023O
 20.12.2022Zentiva, k.s. (ZNT-1)9996DLevosimendan Zentiva (con inf 1x5 ml/12,5 mg (liek.skl.inj.))20.12.2022U
 31.5.2023Zentiva, k.s. (ZNT-1)9996DLevosimendan Zentiva (con inf 1x5 ml/12,5 mg (liek.skl.inj.))31.5.2023R
 4.7.2023Zentiva, k.s. (ZNT-1)9996DLevosimendan Zentiva (con inf 1x5 ml/12,5 mg (liek.skl.inj.))4.7.2023O
 8.8.2023Zentiva, k.s. (ZNT-1)9996DLevosimendan Zentiva (con inf 1x5 ml/12,5 mg (liek.skl.inj.))8.8.2023R
 23.8.2023Zentiva, k.s. (ZNT-1)9996DLevosimendan Zentiva (con inf 1x5 ml/12,5 mg (liek.skl.inj.))24.8.2023O
 31.5.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)99949Ciprofloxacín Sandoz 500 mg filmom obalené tablety (tbl flm 20x500 mg (blis.PP/Al))31.5.2023R
 13.2.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)99949Ciprofloxacín Sandoz 500 mg filmom obalené tablety (tbl flm 20x500 mg (blis.PP/Al))12.2.2024O
 2.5.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)99946Ciprofloxacín Sandoz 500 mg filmom obalené tablety (tbl flm 10x500 mg (blis.PP/Al))2.5.2022R
 22.6.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)99946Ciprofloxacín Sandoz 500 mg filmom obalené tablety (tbl flm 10x500 mg (blis.PP/Al))15.6.2022O
 7.2.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)99946Ciprofloxacín Sandoz 500 mg filmom obalené tablety (tbl flm 10x500 mg (blis.PP/Al))7.2.2023R
 13.2.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)99946Ciprofloxacín Sandoz 500 mg filmom obalené tablety (tbl flm 10x500 mg (blis.PP/Al))12.2.2024O
 19.9.2022GlaxoSmithKline Consumer Healthcare Czech Republic s.r.o. (GAG-CZ)9989CPANADOL PRE DETI JAHODA 24 mg/ml (sus por 1x100 ml (fľ.skl. hnedá+8 ml aplikátor-povolenie uvádzať na trh končí dňa 28.02.2023))16.9.2022Z
 14.12.2023Orion Corporation (ORN)99860BECLOMET NASAL AQUA 100 µg (aer nas 1x23 ml/200 dávok (fľ.HDPE))14.12.2023R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To